Audet Nicolas, Archer-Lahlou Elodie, Richard-Lalonde Mélissa, Piñeyro-Filpo Graciela
Départements de pharmacologie et de psychiatrie, Université de Montréal, Montréal, Canada.
Med Sci (Paris). 2010 Aug-Sep;26(8-9):734-9. doi: 10.1051/medsci/2010268-9734.
Opiates are the most effective analgesics available for the treatment of severe pain. However, their clinical use is restricted by unwanted side effects such as tolerance, physical dependence and respiratory depression. The strategy to develop new opiates with reduced side effects has mainly focused on the study and production of ligands that specifically bind to different opiate receptors subtypes. However, this strategy has not allowed the production of novel therapeutic ligands with a better side effects profile. Thus, other research strategies need to be explored. One which is receiving increasing attention is the possibility of exploiting ligand ability to stabilize different receptor conformations with distinct signalling profiles. This newly described property, termed functional selectivity, provides a potential means of directing the stimulus generated by an activated receptor towards a specific cellular response. Here we summarize evidence supporting the existence of ligand-specific active conformations for two opioid receptors subtypes (delta and mu), and analyze how functional selectivity may contribute in the production of longer lasting, better tolerated opiate analgesics. double dagger.
阿片类药物是治疗重度疼痛最有效的镇痛药。然而,它们的临床应用受到诸如耐受性、身体依赖性和呼吸抑制等不良副作用的限制。开发副作用较小的新型阿片类药物的策略主要集中在研究和生产特异性结合不同阿片受体亚型的配体。然而,这一策略尚未产生具有更好副作用特征的新型治疗性配体。因此,需要探索其他研究策略。其中一个受到越来越多关注的策略是利用配体稳定具有不同信号特征的不同受体构象的能力。这种新描述的特性,称为功能选择性,为将激活受体产生的刺激导向特定细胞反应提供了一种潜在手段。在这里,我们总结了支持两种阿片受体亚型(δ和μ)存在配体特异性活性构象的证据,并分析了功能选择性如何有助于生产作用更持久、耐受性更好的阿片类镇痛药。‡